Skip to main content

IDWeek 2024 Main banner

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Presentation Icons

Live Streamed

On Demand

Back

Sherry Siegert, PharmD

Innoviva Specialty Therapeutics, Inc.

Disclosure(s): Innoviva Specialty Therapeutics: Stocks/Bonds (Public Company); Innoviva Specialty Therapeutics, Inc.: Employee

Poster(s):

(P-1532) Surveillance of Eravacycline Against Clinical Pathogens, Including Resistant Isolates, Collected Worldwide from Multiple Infection Sites During 2018-2022

Friday, October 18, 2024
12:15 PM – 1:30 PM US PT